GlassScriptPhysician profile
Krystina L Eubanks
NPI 1295099547
$5,466.11
in general payments reported to CMS, 2019-2025
22 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $282 · 2021: $924 · 2022: $835 · 2023: $748 · 2024: $868 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,420 · Entertainment: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,419.71 |
| Entertainment | $202.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,272.89 | 2019-2025 | Total30, Clareon Panoptix Pro, Precision7 |
| Bausch & Lomb Americas INC. | $1,144.46 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $499.61 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $436.64 | 2019-2021 | |
| Allergan, INC. | $283.81 | 2020-2022 | |
| Optos, INC. | $202.50 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $198.02 | 2022-2025 | |
| Coopervision INC. | $195.13 | 2019-2023 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $155.24 | 2024-2025 | Tyrvaya |
| Dompe US, INC. | $146.28 | 2024 | Oxervate |
| Biotissue Holdings INC. | $145.12 | 2019-2020 | |
| New World Medical,INC. | $139.07 | 2022 | |
| Shire North American Group INC | $129.04 | 2019 | |
| Sun Pharmaceutical Industries INC. | $125.00 | 2024 | |
| Lkc Technologies, INC. | $123.02 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $74.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $67.26 | 2019-2023 | |
| Abb Con-Cise Optical Group LLC | $41.46 | 2023 | Spectacle Lenses, Contact Lens |
| Amgen INC. | $33.34 | 2024 | Tepezza |
| Cochlear Americas | $25.88 | 2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Carl Zeiss Meditec USA, INC. | $15.13 | 2024 | Humphrey Hfa |
| Horizon Therapeutics Plc | $13.10 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystina Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.